Nature Communications (Nov 2019)

Engineering dendritic cell vaccines to improve cancer immunotherapy

  • Caleb R. Perez,
  • Michele De Palma

DOI
https://doi.org/10.1038/s41467-019-13368-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 10

Abstract

Read online

Dendritic cells (DCs) have been explored as a promising strategy for cancer immunotherapy. In this Perspective, the authors discuss the different types of DCs and their therapeutic potential in the context of vaccines for personalized cancer therapy.